NSE filing, NSE: KIMS. Summary written from the filing by ALFA Finder's alert engine.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹745.35
- Market cap
- ₹31,305 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 153.2×Sector 53.8×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Krishna Institute of Medical Sciences Management Change
KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.
- Execution
- 5 years
Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways
Q2 FY27 total revenue Rs13,630 Mn (+41.3% YoY), EBITDA Rs2,789 Mn (20.5% margin), PAT Rs757 Mn (+5.1% YoY). Expansion via 700+ beds planned.
Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.6 Cr · +3.6% YoY
Krishna Institute of Medical Sciences Capacity Expansion
KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.
- hospital beds
- 250.0 beds
Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Other results update announcements
All →Vindhya Telelinks Results Update
Vindhya Telelinks reported Q2 FY27 standalone PAT of ₹5781.42 lakhs, up 82% year-on-year, with Cable EBITDA up over 250%. The press release also covers EPC receivables and the proposed Birla Cable amalgamation.
Golkunda Diamonds & Jewellery Results Update
Golkunda Diamonds reported Q2 FY27 PAT up 113.23% and revenue up 7.92%. It also launched NIBHANA, a lab-grown diamond jewellery retail brand, with four stores open.
- NIBHANA retail stores
- 4.0 stores
Godavari Biorefineries Results Update
Q2 FY27 revenue rose 26.6% YoY to Rs.549.8 Crore, with EBITDA turning positive. Net loss narrowed to Rs.15.2 Crore from Rs.41.6 Crore a year earlier.
Aurobindo Pharma Results Update
Aurobindo Pharma reported Q2 FY27 revenue of Rs.10,263 Crore, up 23.9% YoY, and net profit of Rs.1,124 Crore. An interim dividend of Rs.7 per share was declared.
Stove Kraft Results Update
Stove Kraft reported Q2 FY27 revenue of Rs.584.7 Crore, up 23.2% YoY, with PAT up 35.7% to Rs.29.0 Crore. The investor release also covers channel and store expansion.
Afcons Infrastructure Results Update
Afcons Infrastructure released Q2 and H1 FY27 results, with profit sharply lower year-on-year. Pending order book stood at ₹43,837 Cr as of September 2026.